Mechanisms of hepatocyte growth factor activation in cancer tissues.
about
Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer.Hepatocyte growth factor/MET in cancer progression and biomarker discoveryCarboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents.Targeting the MET pathway for potential treatment of NSCLC.Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation.Gene of the month: MET.Understanding STAT3 signaling in cardiac ischemia.α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma.Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.Probing conformational and functional states of human hepatocyte growth factor by a panel of monoclonal antibodiesTargeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model.The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to β amyloid.Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma.Activated HGF-c-Met Axis in Head and Neck Cancer.Transcriptome-wide analysis suggests that temporal changes in the relative contributions of hyperplasia, hypertrophy and apoptosis underlie liver growth in pregnant mice.Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.Molecular Regulation of Sprouting Angiogenesis.Role of the Nervous System in Tumor Angiogenesis.Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells.Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
P2860
Q37544362-C3E84345-3B98-48F2-9B34-DCA22A48DD44Q37650102-C6312963-0CBD-4DF6-BA29-76A2EA274E12Q37735624-F77967DE-7B6A-4894-82FA-BA32958DE4E3Q37737964-A905969D-6501-4C6B-878E-30289B0F8E1CQ38297235-01623E38-40B6-48EF-93C2-E225D903E631Q38433828-0787C022-6A51-4F2F-BE33-262C65B81AF7Q38490458-DD8CD861-7C12-4C06-B67A-6FB6AF48AA3AQ38790211-89DCDC86-02CA-4C09-BE13-7C3110C8C35DQ38793227-131C4CD7-E8F8-490E-A78B-41D4AF2A7CDDQ38831784-5F51F21D-33F6-41C1-8A06-D8DF3E08A1B3Q39428273-A167D9C3-12D4-4457-BFA0-155017736349Q39816968-A9EDD59B-1A62-4E35-91B1-3BECAEAABC40Q41051656-8D35F613-21CE-49DB-AE6A-C495C46B1856Q41825773-0D0C1C86-F14C-44F1-9B33-AC8FEC4FF4A6Q42058767-3BAE988A-1845-4BBF-96E9-B086DA78BBD3Q42254033-B8B089DF-D08A-46A4-960A-2B892BA1169EQ42778244-7A1489F7-B62A-4DC3-AF5D-2AE6437973C5Q47133508-AEABA959-3E78-4AE2-99AF-3F9F97946B7AQ47303095-043598C4-7852-452D-8D48-64CB5A7318E6Q47676243-5695F24A-86CD-4662-96F0-A5DA630DC57DQ49545332-967B085A-C75C-4C68-840A-E7F39A6FA986Q50423780-A8D98C41-E43A-4288-97DC-98A87F02883BQ52675438-EF09D59B-1F6A-40C9-B676-B971B15A75A6Q54254288-9FDB8F86-FC69-4745-B5CC-1E5A4EC320CAQ55343941-D5DA867C-C688-4D08-991A-C7FF36A4A628Q55456643-5CA01CEE-1E66-4206-982E-C106A35AA394Q58760425-C3632ED3-10FD-4AE6-B164-E9F61D31FDFF
P2860
Mechanisms of hepatocyte growth factor activation in cancer tissues.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Mechanisms of hepatocyte growth factor activation in cancer tissues.
@en
type
label
Mechanisms of hepatocyte growth factor activation in cancer tissues.
@en
prefLabel
Mechanisms of hepatocyte growth factor activation in cancer tissues.
@en
P2860
P356
P1433
P1476
Mechanisms of hepatocyte growth factor activation in cancer tissues.
@en
P2093
Hiroaki Kataoka
Makiko Kawaguchi
P2860
P304
P356
10.3390/CANCERS6041890
P577
2014-09-29T00:00:00Z